<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Res Protoc</journal-id><journal-id journal-id-type="publisher-id">ResProt</journal-id><journal-id journal-id-type="index">5</journal-id><journal-title>JMIR Research Protocols</journal-title><abbrev-journal-title>JMIR Res Protoc</abbrev-journal-title><issn pub-type="epub">1929-0748</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v15i1e95229</article-id><article-id pub-id-type="doi">10.2196/95229</article-id><article-categories><subj-group subj-group-type="heading"><subject>Protocol</subject></subj-group></article-categories><title-group><article-title>A Clinician-Supported Mobile App to Reduce Mental Health Symptoms Among World Trade Center Responders in Florida: Protocol for a Randomized Controlled Trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Macgowan</surname><given-names>Mark J</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Possemato</surname><given-names>Kyle</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kuhn</surname><given-names>Eric</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hu</surname><given-names>Nan</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lowe</surname><given-names>Sandra</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Garcia</surname><given-names>Stephanie</given-names></name><degrees>MPH</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Panellas</surname><given-names>Isis</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Edwards</surname><given-names>Arrianna</given-names></name><degrees>MSW</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gray</surname><given-names>Victoria</given-names></name><degrees>MSW</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Marquez</surname><given-names>Ruth</given-names></name><degrees>MPH, MS</degrees><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pitta</surname><given-names>Luciana</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lucchini</surname><given-names>Roberto G</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff6">6</xref></contrib></contrib-group><aff id="aff1"><institution>School of Social Work, Robert Stempel College of Public Health and Social Work, Florida International University</institution><addr-line>11200 SW 8th Street, AHC5-513</addr-line><addr-line>Miami</addr-line><addr-line>FL</addr-line><country>United States</country></aff><aff id="aff2"><institution>Syracuse VA Medical Center</institution><addr-line>New York</addr-line><addr-line>NY</addr-line><country>United States</country></aff><aff id="aff3"><institution>VA National Center for PTSD</institution><addr-line>Palo Alto</addr-line><addr-line>CA</addr-line><country>United States</country></aff><aff id="aff4"><institution>Department of Biostastistics, Robert Stempel College of Public Health and Social Work, Florida International University</institution><addr-line>Miami</addr-line><addr-line>FL</addr-line><country>United States</country></aff><aff id="aff5"><institution>Icahn School of Medicine, Mount Sinai</institution><addr-line>New York</addr-line><addr-line>NY</addr-line><country>United States</country></aff><aff id="aff6"><institution>Department of Environmental Health Sciences, Robert Stempel College of Public Health and Social Work, Florida International University</institution><addr-line>Miami</addr-line><addr-line>FL</addr-line><country>United States</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Sarvestan</surname><given-names>Javad</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Mark J Macgowan, PhD, School of Social Work, Robert Stempel College of Public Health and Social Work, Florida International University, 11200 SW 8th Street, AHC5-513, Miami, 33199, FL, United States, 1 3053480427; <email>macgowan@fiu.edu</email></corresp></author-notes><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>30</day><month>6</month><year>2026</year></pub-date><volume>15</volume><elocation-id>e95229</elocation-id><history><date date-type="received"><day>19</day><month>03</month><year>2026</year></date><date date-type="rev-recd"><day>04</day><month>05</month><year>2026</year></date><date date-type="accepted"><day>08</day><month>05</month><year>2026</year></date></history><copyright-statement>&#x00A9; Mark J Macgowan, Kyle Possemato, Eric Kuhn, Nan Hu, Sandra Lowe, Stephanie Garcia, Isis Panellas, Arrianna Edwards, Victoria Gray, Ruth Marquez, Luciana Pitta, Roberto G Lucchini. Originally published in JMIR Research Protocols (<ext-link ext-link-type="uri" xlink:href="https://www.researchprotocols.org">https://www.researchprotocols.org</ext-link>), 30.6.2026. </copyright-statement><copyright-year>2026</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="https://www.researchprotocols.org">https://www.researchprotocols.org</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://www.researchprotocols.org/2026/1/e95229"/><abstract><sec><title>Background</title><p>World Trade Center (WTC) general responders (GRs) continue to experience long-term mental health conditions, including posttraumatic stress disorder (PTSD), depression, anxiety, and sleep disturbance. A growing number of GRs reside in Florida, where barriers such as stigma, limited access to specialty care, and age-related limitations contribute to persistent unmet mental health needs. PTSD Coach, a mobile app originally developed for trauma-exposed veterans, has shown promise but has not been evaluated with WTC GRs or adapted for Spanish-speaking responders.</p></sec><sec><title>Objective</title><p>This study aims to evaluate the feasibility, acceptability, and efficacy of Clinician-Supported (CS) PTSD Coach for reducing PTSD symptoms among English-speaking and Spanish-speaking WTC GRs living in Florida. Secondary objectives include evaluating effects on depression, anxiety, and sleep disturbance; comparing CS PTSD Coach with Self-Managed (SM) PTSD Coach and a waitlist control; and adapting and delivering a Spanish-language version of the intervention.</p></sec><sec sec-type="methods"><title>Methods</title><p>This study is a 3-arm randomized controlled trial comparing CS PTSD Coach, SM PTSD Coach, and a waitlist control for reducing PTSD, depression, anxiety, and sleep disturbance among English-speaking and Spanish-speaking WTC GRs living in Florida. A total of 120 participants are randomized and assessed at baseline, 8 weeks, and a 12-week follow-up. CS PTSD Coach includes 4 clinician-guided sessions integrated with app-based activities, whereas SM PTSD Coach includes a single orientation session. Outcomes include PTSD symptoms (PTSD Checklist for DSM-5), depression (Patient Health Questionnaire-9), anxiety (Generalized Anxiety Disorder-7), and sleep disturbance (Insomnia Severity Index). Feasibility and acceptability are assessed using app use data, satisfaction ratings, and usability measures. Primary analyses focus on between-group differences after the intervention (8 weeks), with secondary longitudinal analyses incorporating all assessment time points.</p></sec><sec sec-type="results"><title>Results</title><p>The notice of award was received in September 2024, and institutional review board approval, including amendments, was granted in January 2025. Recruitment began in February 2025, with data collection initiated in March 2025. As of April 2026, 63 participants have been enrolled, and outcome data collection is ongoing. Data analysis will commence following completion of follow-up assessments, with dissemination of results anticipated in 2027.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>This trial will provide the first randomized controlled evaluation of a clinician-supported mobile PTSD intervention for WTC responders, including Spanish-speaking GRs. Findings will inform the feasibility, acceptability, and potential scalability of supported digital mental health interventions for aging, geographically dispersed disaster-exposed populations.</p></sec><sec><title>Trial Registration</title><p>ClinicalTrials.gov NCT06648928; https://clinicaltrials.gov/study/NCT06648928</p></sec><sec sec-type="registered-report"><title>International Registered Report Identifier (IRRID)</title><p>DERR1-10.2196/95229</p></sec></abstract><kwd-group><kwd>World Trade Center</kwd><kwd>first responders</kwd><kwd>PTSD Coach</kwd><kwd>mobile health</kwd><kwd>randomized clinical trial</kwd><kwd>posttraumatic stress disorder</kwd><kwd>PTSD</kwd><kwd>depression</kwd><kwd>anxiety</kwd><kwd>sleep problems</kwd><kwd>mobile phone</kwd></kwd-group><custom-meta-wrap><custom-meta><meta-name>ext-peer-rev</meta-name><meta-value>The proposal for this study was peer-reviewed by ZOH1 LEE (52) - Disease, Disability and Injury Prevention and Control Special Emphasis Panel, WTC Research Review, Centers for Disease Control and Prevention-National Institute for Occupational Health and Safety. See Peer Review Report for details</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><sec id="s1-1"><title>Background and Rationale</title><p>The World Trade Center Health Program (WTCHP), funded by the Centers for Disease Control and Prevention and the National Institute for Occupational Safety and Health (NIOSH) since 2011, provides medical monitoring and treatment for September 11, 2001 (9/11)-related conditions to more than 140,000 individuals, with enrollment increasing by about 6% annually [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>]. Research on the World Trade Center (WTC) cohort has documented WTC-related mental health conditions that include posttraumatic stress disorder (PTSD) as the most commonly certified psychiatric condition with a prevalence ranging from 3.8% to 29.6% [<xref ref-type="bibr" rid="ref3">3</xref>], as well as anxiety, depression, substance abuse, and sleep disturbances [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref5">5</xref>]. Most of these conditions show a chronic or persistent course, with symptoms lasting for years after exposure. As of September 2023, the WTCHP has certified WTC-related mental health conditions in about 17% of responders and survivors [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>].</p><p>Many general responders (GRs)&#x2014;workers or volunteers involved in rescue, recovery, cleanup efforts, or related support services&#x2014;experience significant symptoms of subthreshold PTSD (ie, <underline>&#x003C;</underline>30 on PTSD Checklist for DSM-5 [PCL-5]) [<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref>]. Overall, 26.8% of police and 46% of nontraditional responders (eg, construction and demolition workers, and volunteers) met the criteria for probable WTC-related full or subthreshold PTSD an average of 12 years after 9/11 [<xref ref-type="bibr" rid="ref8">8</xref>]. GRs with subthreshold PTSD commonly experience significant distress and long-lasting functional impairment related to specific sets of symptoms, such as hypervigilance and avoidance [<xref ref-type="bibr" rid="ref9">9</xref>], which highlight the need for assessment and treatment [<xref ref-type="bibr" rid="ref8">8</xref>]. Almost 20 years after 9/11, nearly half of nontraditional responders and a fifth of police responders reported a need for mental health support [<xref ref-type="bibr" rid="ref10">10</xref>].</p><p>However, rates of those seeking mental health services are lower than expected [<xref ref-type="bibr" rid="ref11">11</xref>], and perceived unmet mental healthcare need is persistent [<xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref13">13</xref>]. A focus group study on WTC GRs underlined the systematic challenges to accessing mental health care [<xref ref-type="bibr" rid="ref14">14</xref>]. Some of the challenges included stigma, lack of institutional recognition of PTSD, limited treatment options, and practical obstacles such as transportation and age-related bias. These recurring challenges underscored the study&#x2019;s conclusion that responders face entrenched, system-level obstacles to obtaining needed care.</p><p>In 2012 and 2014, the WTCHP Scientific Technical Advisory Committee recommended research on mental health interventions [<xref ref-type="bibr" rid="ref15">15</xref>] and the <italic>&#x201C;</italic>effectiveness and utility of PTSD treatments<italic>&#x201D;</italic> [<xref ref-type="bibr" rid="ref16">16</xref>]. A 2020 review based on the National Institute of Environmental Health Sciences translational research framework [<xref ref-type="bibr" rid="ref17">17</xref>] noted that although clinical interventions in the WTCHP included a wide range of options [<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref18">18</xref>-<xref ref-type="bibr" rid="ref24">24</xref>], there were few controlled studies. Most interventions were delivered in person with highly exposed individuals [<xref ref-type="bibr" rid="ref3">3</xref>]. At the time this study was developed, no studies were conducted with mobile app&#x2013;based remote interventions to serve the large number of GRs with full or subthreshold PTSD. Furthermore, no interventions focused on Spanish-speaking Hispanic GRs have been conducted.</p><p>Studies of PTSD interventions for which current evidence has been supportive in other populations (eg, military veterans) can be used to advance care for GRs along the translational spectrum [<xref ref-type="bibr" rid="ref17">17</xref>]. Furthermore, WTC researchers have strongly recommended trials that include tele-mental health [<xref ref-type="bibr" rid="ref17">17</xref>].</p></sec><sec id="s1-2"><title>Growing WTC Subcohort in Florida</title><p>The number of eligible WTCHP members relocating to Florida has steadily risen over the years. National distribution figures of WTC members with a National Providers Network assignment show Florida as the largest location [<xref ref-type="bibr" rid="ref25">25</xref>]. Additional data from the WTCHP General Responder Data Center (GRDC) reported that 7346 GRs were registered with a Florida address in 2025 [<xref ref-type="bibr" rid="ref26">26</xref>]. In collaboration with the WTCHP GRDC, our research group conducted a secondary data analysis of the data on GRs living in Florida in 2023. The WTC GRs in Florida, for whom monitoring data were available (N=3124), were on average aged just over 60 years (61.4, SD 8.5 years), frequently retired (n=1252, 44.6%), male (n=2292, 81.6%), and of Hispanic ethnicity (n=727, 25.9%). Some WTC GRs (n=370, 15.1%) had a WTC-related mental health condition.</p><p>In addition to the secondary data analysis, our team surveyed Florida WTC GRs in August 2023 about their research interests. A total of 244 GRs responded and expressed strong interest in PTSD and sleep-related studies (n=127, 52% and n=185, 76%, respectively). Although the preference for receiving support was for in-person interventions (n=107, 44%), 22% (n=44) of respondents expressed a preference for app-based or remote modalities, and an additional 44% (n=107) reported no opposition to their use.</p><p>This study responds to one of the research areas of the Zadroga Act (Title 42 USC &#x00A7;300 mm&#x2013;51) to treat <italic>&#x201C;</italic>WTC-related health conditions for which there has been treatment uncertainty<italic>&#x201D;</italic> and, by including Spanish-speaking Hispanic GRs, helps advance health equity as required in Notice of Funding Opportunity issued by the National Institutes of Health Office of Human Resources (NOT-OH-23&#x2010;002).</p><p>The focus on this subcohort of the GRs in Florida is especially relevant, given that members generally relocate to Florida upon retirement and are older compared to GRs living elsewhere. As this subcohort continues to grow, aging may intersect with the long-term mental health effects associated with 9/11 exposures. Relocation can disrupt continuity of mental health care; embedding a supported digital intervention within the WTCHP and the National Providers Network may help sustain engagement and reduce symptoms during relocation, including among Spanish-speaking responders.</p><p>Persistent symptom burden alongside underuse of care reflects enduring barriers, including stigma, travel demands, limited specialty availability, and challenges faced by retired or older responders, such as reduced mobility and progression of medical conditions. App-based, clinician-supported care offers a scalable approach to addressing these barriers while preserving trauma-informed treatment strategies in a geographically dispersed cohort.</p></sec><sec id="s1-3"><title>Aims of the Study</title><p>The overarching goal of the study is to assess the feasibility, acceptability, and efficacy of Clinician-Supported (CS) PTSD Coach, originally developed for English-speaking military veterans [<xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref28">28</xref>] but never tested with WTCHP members, for reducing symptoms of PTSD, depression, anxiety, and sleep disturbance among multiethnic English-speaking and Spanish-speaking GRs in Florida. The four primary aims are to (1) assess the feasibility of CS PTSD Coach with GRs living in Florida; (2) evaluate the acceptability of CS PTSD Coach; (3) determine the efficacy of CS PTSD Coach in reducing PTSD, depression, anxiety, and sleep symptoms through a controlled trial; and (4) develop and deliver a Spanish-language version of CS PTSD Coach.</p></sec><sec id="s1-4"><title>Hypotheses and Exploratory Analyses</title><p>If both the CS and SM PTSD Coach interventions demonstrate improvements relative to the waitlist control, we will conduct direct comparisons between CS and SM PTSD Coach to evaluate differential symptom reduction. We hypothesize that CS PTSD Coach will result in greater reductions in PTSD, depression, anxiety, and sleep disturbance due to the addition of clinician support.</p><p>We also explore potential moderators and mediators of treatment effects, including baseline PTSD severity, sex, race, ethnicity, language, and engagement level. These analyses are exploratory and intended to inform future hypothesis-driven studies.</p><p>The fourth aim focuses on developing and delivering a Spanish-language version of CS PTSD Coach. The existing English-language clinician manual has been adapted for 9/11 responders and translated into Spanish. The adapted intervention is delivered by bilingual or bicultural clinicians, and its feasibility, acceptability, and preliminary efficacy evaluated using the same measures as the English-language intervention.</p></sec></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Study Design</title><p>The study design in the 2-year project includes a 3-arm randomized controlled trial (RCT) of the experimental intervention CS PTSD Coach, compared to Self-Managed (SM) PTSD Coach and a waitlist control, with each group assessed at baseline, immediate postintervention (8 weeks), and follow-up (12 weeks). The RCT design combines feasibility, acceptability, and efficacy based on CS PTSD Coach effectiveness with English-speaking veterans in the Department of Veterans Affairs (VA) [<xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref28">28</xref>]. Feasibility, acceptability, and efficacy data will fill the gap of knowledge on mental health interventions specifically for the WTC GRs and especially for the Spanish-speaking population. This design achieves a balance between efficacy (internal validity) and clinical utility (external validity) [<xref ref-type="bibr" rid="ref29">29</xref>] by including an RCT and collecting data on the acceptability and feasibility of both the CS and SM versions of PTSD Coach for English and Spanish speakers. Although we predict that the CS version will be more efficacious than SM PTSD Coach, given the added support [<xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref30">30</xref>], the design also yields valuable information about 2 interventions.</p><p>In addition to efficacy and clinical utility, additional strengths include manualized treatment and theory-driven and data-driven hypotheses and treatment. Additionally, we plan to explore several potential moderators and mediators, which may predict differential treatment outcomes.</p><p>The trial was registered with ClinicalTrials.gov (NCT06648928) before participant enrollment. Protocol development and reporting followed the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013 guidelines for clinical trial protocols.</p></sec><sec id="s2-2"><title>Randomization and Groups</title><p>As indicated in <xref ref-type="fig" rid="figure1">Figure 1</xref>, after baseline assessment, participants are assigned based on a random number generator on a rolling basis into three groups: (1) experimental treatment CS PTSD Coach, (2) alternative treatment SM PTSD Coach, and (3) a waitlist control that receives no treatment until after the follow-up assessment. Allocation concealment is supported by using sequentially numbered, opaque, sealed envelopes prepared by an individual not involved in assessment or intervention; envelopes are opened sequentially after participant enrollment.</p><fig position="float" id="figure1"><label>Figure 1.</label><caption><p>Study design. CS: Clinician-Supported; PTSD: posttraumatic stress disorder; SM: Self-Managed.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="resprot_v15i1e95229_fig01.png"/></fig><p>After assignment, participants receive CS PTSD Coach, SM PTSD Coach, or the waitlist control group. Participants in all 3 groups are assessed at 8 weeks (the typical duration of the CS PTSD Coach) and 4 weeks later at follow-up (12 weeks). At that point, participants in the waitlist control group are given the choice of CS or SM PTSD Coach but are not further evaluated. This approach was adopted for ethical reasons to provide all participants with a choice of treatment at the end.</p></sec><sec id="s2-3"><title>Participants</title><p>WTC GRs currently living in Florida, of any age, with PCL-5 scores consistent with subthreshold or clinical PTSD (eg, <italic><underline>&#x003E;</underline></italic>27) are included. Participants are introduced to the project through a contact via SMS text messaging, email, or letter by the recruitment team. To be included, participants must have a smartphone capable of running PTSD Coach (available on both Android and iOS platforms) and be fluent in either English or Spanish.</p><p>Exclusion criteria determined by the initial screening with the assessors include (1) active or recent (past month) suicidal ideation or attempt; (2) severe alcohol use measured by an Alcohol Use Disorders Identification Test score of 20+ [<xref ref-type="bibr" rid="ref31">31</xref>]; (3) except for cannabis, no use of illicit or unprescribed drugs in the last 2 weeks as indicated on the American Psychiatric Association Level 2 Substance Use Measure [<xref ref-type="bibr" rid="ref32">32</xref>]; (4) presence of neurologic or neurodegenerative conditions associated with significant cognitive impairment measured using the Blessed Orientation-Memory-Concentration test [<xref ref-type="bibr" rid="ref33">33</xref>]; and (5) current mental health counseling for PTSD (primary outcome) to avoid confounding effects. Participants endorsing active suicidal ideation during screening receive an immediate safety evaluation and are provided referrals to appropriate mental health services or emergency care, with follow-up outreach conducted when clinically appropriate.</p></sec><sec id="s2-4"><title>Recruitment</title><p>Recruitment benefits from the network established in an ongoing survey targeting Florida WTC GRs and is supported by bilingual outreach staff. The recruitment strategy uses two consecutive approaches: (1) direct contact via email, phone, and home address of WTCHP members who consented to be contacted for research, with information provided by the WTCHP GRDC and (2) public outreach through university and electronic releases, a website, and participation in local emergency responder events, facilitated through established contacts with WTC firefighters and law enforcement representatives residing in Florida.</p></sec><sec id="s2-5"><title>Sample Size Calculation</title><p>The rationale for selecting a sample size of 120 participants, 40 per group across the 3 arms of the RCT (CS PTSD Coach, SM PTSD Coach, and waitlist control), is based on achieving sufficient statistical power to detect meaningful differences in the outcomes. As the primary analysis is to compare the preintervention (baseline) and postintervention (8 weeks) change in outcomes across intervention arms, analysis of covariance (ANCOVA) serves as the primary between-group analytic approach as it is the most powerful model for pre- and postanalysis. Specifically, with 10% expected data attrition, this sample size will provide 80% power to detect a minimal difference of 0.30 SDs between-group means using ANCOVA with a significance level of <italic>P</italic>&#x003C;.05. The design assumes a common within-group SD of 1.00 and covariates with an R-squared of 0.20, ensuring robust comparisons across interventions while accounting for potential confounding variables.</p></sec><sec id="s2-6"><title>Interventions</title><p>PTSD Coach was developed by the VA&#x2019;s National Center for PTSD Dissemination and Training Division as a self-managed mobile app that contains 4 sections: learn, self-assessment, manage symptoms, and find support [<xref ref-type="bibr" rid="ref34">34</xref>]. The app is available at no cost from the App Store and Google Play marketplaces [<xref ref-type="bibr" rid="ref35">35</xref>] and thus reaches almost all (99.5%) US smartphone users [<xref ref-type="bibr" rid="ref36">36</xref>]. For this research project, the app is available in both English and Spanish. The primary focus of PTSD Coach is on PTSD symptoms, which include (1) reexperiencing, such as having intrusive traumatic symptoms (eg, flashbacks and nightmares); (2) persistent avoidance of stimuli associated with the traumatic event; (3) negative thoughts or feelings that worsened after the traumatic event; and (4) hyperarousal, such as sleep disturbance, excessive startle reactions, and irritable behavior [<xref ref-type="bibr" rid="ref37">37</xref>]. PTSD Coach provides psychoeducation on trauma and PTSD and helps trauma-exposed individuals to monitor and manage traumatic stress symptoms. PTSD often cooccurs with depression and anxiety, and PTSD Coach is also effective on these symptoms [<xref ref-type="bibr" rid="ref38">38</xref>], but it was never studied with GRs. Sleep disturbance is a common complaint among WTC responders [<xref ref-type="bibr" rid="ref5">5</xref>], and veterans have reported that the mobile app has helped them with sleep problems [<xref ref-type="bibr" rid="ref34">34</xref>]. In summary, the PTSD Coach app focuses on targeting the primary mechanisms of PTSD and associated symptoms of depression, anxiety, and sleep disturbance.</p><p>CS PTSD Coach was developed as a brief intervention for veteran primary care patients with elevated PTSD symptoms who were unlikely to use a mobile app on their own [<xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref39">39</xref>]. CS PTSD Coach is a manualized intervention that combines the PTSD Coach mobile app with four 20-to-30-minute sessions delivered over 8 weeks. Sessions focus on instructions for app use, setting symptom reduction goals, and assigning PTSD Coach activities (ie, symptom monitoring, management strategies, and psychoeducational readings) for completion between sessions. The clinician sessions help participants select the management strategies within the app that can best address their PTSD symptoms and incorporate these strategies into their daily lives. As part of aim 4, the existing treatment manual developed for veterans will be adapted for the GRs, including translating it into Spanish. The main components of each session are shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p><table-wrap id="t1" position="float"><label>Table 1.</label><caption><p>Clinician-Supported PTSD Coach overview and fidelity elements.</p></caption><table id="table1" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Session 1</td><td align="left" valign="bottom">Sessions 2 and 3</td><td align="left" valign="bottom">Session 4</td></tr><tr><td align="left" valign="bottom">Format</td><td align="left" valign="bottom">Audio or audio and video</td><td align="left" valign="bottom">Audio or audio and video</td><td align="left" valign="bottom">Audio or audio and video</td></tr></thead><tbody><tr><td align="left" valign="top">Content</td><td align="left" valign="top"><list list-type="bullet"><list-item><p>Overview of treatment</p></list-item><list-item><p>Instructions for app use</p></list-item><list-item><p>Discuss learn modules</p></list-item><list-item><p>Complete PCL-5<sup><xref ref-type="table-fn" rid="table1fn1">a</xref></sup> in app</p></list-item><list-item><p>Target problem domain</p></list-item><list-item><p>Try 1-2 manage strategies</p></list-item></list></td><td align="left" valign="top"><list list-type="bullet"><list-item><p>Review homework</p></list-item><list-item><p>Discuss change on PCL-5 graph</p></list-item><list-item><p>Discuss manage strategies used</p></list-item><list-item><p>Target new symptom domain to manage</p></list-item><list-item><p>Problem solve any adherence issues</p></list-item></list></td><td align="left" valign="top"><list list-type="bullet"><list-item><p>Review homework</p></list-item><list-item><p>Discuss Learn, assessment, and manage tools used since last session</p></list-item><list-item><p>Recommend treatment based on PCL-5 score</p></list-item><list-item><p>Make treatment or self-management plan</p></list-item></list></td></tr><tr><td align="left" valign="top">Homework</td><td align="left" valign="top"><list list-type="bullet"><list-item><p>Complete PCL-5 weekly</p></list-item><list-item><p>Read at least 2 Learn topics</p></list-item><list-item><p>Use manage strategies daily</p></list-item></list></td><td align="left" valign="top"><list list-type="bullet"><list-item><p>Complete PCL-5 weekly</p></list-item><list-item><p>Read at least 2 Learn topics</p></list-item><list-item><p>Use manage strategies daily</p></list-item></list></td><td align="left" valign="top"><list list-type="bullet"><list-item><p>Follow through on treatment plan</p></list-item><list-item><p>Continue to use app as desired</p></list-item></list></td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><p><sup>a</sup>PCL-5: PTSD Checklist for DSM-5.</p></fn></table-wrap-foot></table-wrap><p>CS PTSD Coach is delivered by bilingual or bicultural master&#x2019;s or doctoral students in social work with experience in providing remotely delivered psychosocial care, supervised by a Florida-licensed clinician. The university is a Hispanic-serving institution; most students are bilingual or bicultural Hispanics. The intervention developer leads clinician training that includes didactic training and role plays. During treatment delivery, clinicians participate in weekly group consultation calls with the intervention developer&#x2019;s team. The clinicians complete fidelity checklists of essential protocol components following each session. An independent fidelity assessment will be conducted using audio-recorded sessions for 25% of sessions randomly selected from each of the 4 sessions of the protocol.</p><p>The SM PTSD intervention includes 1 brief session with the clinician who provides basic information about downloading and using the app [<xref ref-type="bibr" rid="ref27">27</xref>]. There are no further instructions with the participants in this group.</p></sec><sec id="s2-7"><title>Measures</title><sec id="s2-7-1"><title>Overview</title><p>The project includes measures to assess clinical outcomes and exploratory implementation (process) outcomes, including satisfaction, feasibility, and acceptability. All outcome measures are administered by research assistant assessors who are blind to conditions and not involved in treatment delivery. The clinical measures are brief, have good psychometrics, and have been used in clinical trials, so they are sensitive to treatment change (when needed, Spanish versions of the measures will be used). Some of the instruments have been used in the WTCHP monitoring program, so would be familiar to respondents. To promote retention and completion of follow-up assessments, participants are contacted using multiple methods and reminded of upcoming assessments, and outcome data are collected remotely to minimize participant burden.</p></sec><sec id="s2-7-2"><title>Clinical Outcomes</title><p>The primary clinical outcome variable, PTSD symptoms, is assessed at all 3 time points (baseline, postintervention, follow-up) using the PCL-5, which has good reliability and validity [<xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref40">40</xref>]. The PCL-5 is used to assess changes in treatment response, with items rated on a 0 (not at all) to 4 (extremely) scale and higher total scores reflecting greater PTSD symptom severity. Studies of expected minimal important difference with the PCL-5 indicated that changes under 5 are unreliable and 9 to 12 points reflect real change [<xref ref-type="bibr" rid="ref41">41</xref>]. Thus, we expect at least a 5-point difference to be reliable change and 9 to reflect clinically meaningful differences. As few PTSD Coach studies have explored changes in specific PTSD symptom clusters [<xref ref-type="bibr" rid="ref38">38</xref>], we will conduct exploratory subscale analyses to identify which clusters respond best to the intervention.</p><p>Depression severity, a secondary clinical outcome, is assessed at all 3 time points using the Patient Health Questionnaire-9 (PHQ-9), a reliable and valid measure [<xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref>] used in similar studies [<xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref44">44</xref>]. The PHQ-9 is a 9-item self-report measure of depression symptoms in the past 2 weeks. Participants rate each item on a 0 (not at all) to 3 (nearly every day) scale. A score of 5 indicates mild depression, 10 to 14 moderate, 15 to 19 moderately severe, and 20 to 27 severe [<xref ref-type="bibr" rid="ref43">43</xref>]. Scores ranging from 8 to 11 suggest major depressive disorder [<xref ref-type="bibr" rid="ref45">45</xref>].</p><p>Anxiety, a secondary clinical outcome, often cooccurs with PTSD [<xref ref-type="bibr" rid="ref37">37</xref>] and is assessed at the 3 time points using the Generalized Anxiety Disorder-7 (GAD-7)[<xref ref-type="bibr" rid="ref46">46</xref>], a 7-item self-report measure of general anxiety symptoms over the past 2 weeks. Respondents rate their anxiety on a scale from 0 (not at all) to 3 (nearly every day). The measure has good reliability and validity [<xref ref-type="bibr" rid="ref46">46</xref>,<xref ref-type="bibr" rid="ref47">47</xref>] and has been used with first responders [<xref ref-type="bibr" rid="ref44">44</xref>]. A score of 8 or higher indicates probable generalized anxiety disorder [<xref ref-type="bibr" rid="ref48">48</xref>,<xref ref-type="bibr" rid="ref49">49</xref>], with cut points of 5, 10, and 15 indicating mild, moderate, and severe levels of anxiety, respectively [<xref ref-type="bibr" rid="ref46">46</xref>].</p><p>Sleep disturbance symptoms, a secondary clinical outcome, is assessed using the 7-item self-report Insomnia Severity Index (ISI) [<xref ref-type="bibr" rid="ref50">50</xref>,<xref ref-type="bibr" rid="ref51">51</xref>]. The ISI assesses the severity and effects of insomnia symptoms over the past 2 weeks. Items are rated on a scale from 0 (no problem) to 4 (very severe problem), yielding a range of 0 to 28, with higher scores reflecting increased severity of insomnia symptoms. Scores of 0 to 7 indicate absence of insomnia, 8 to 14 subthreshold insomnia, 15 to 21 moderate insomnia, and 22 to 28 severe insomnia [<xref ref-type="bibr" rid="ref50">50</xref>]. For clinical trials, a cut score of 11 is recommended [<xref ref-type="bibr" rid="ref51">51</xref>], with a score of 15 indicating clinically significant insomnia symptoms [<xref ref-type="bibr" rid="ref50">50</xref>]. A reduction of &#x003E;7 points indicates optimal change for moderate improvement and a reduction of &#x003E;8 points indicates optimal change for marked improvement [<xref ref-type="bibr" rid="ref51">51</xref>].</p></sec><sec id="s2-7-3"><title>Satisfaction, Feasibility, and Acceptability</title><p>In addition, several exploratory implementation (process) outcomes are intended to capture intervention uptake, user experience, and implementation potential rather than clinical efficacy. Satisfaction with treatment is assessed using the Client Satisfaction Questionnaire, a widely used 8-item self-report measure assessing patient satisfaction with care [<xref ref-type="bibr" rid="ref52">52</xref>,<xref ref-type="bibr" rid="ref53">53</xref>]. Each question is rated on a scale from 1 to 4, with higher scores reflecting increased satisfaction.</p><p>To assess feasibility, responder engagement with the app will be evaluated using objective use data from the app developer (VA Palo Alto Health Care System), including frequency and duration of use, peak use periods, and module-level engagement.</p><p>Treatment acceptability and appropriateness is assessed with the Acceptability of Intervention Measure and Intervention Appropriateness Measure, both consisting of 4 items with good reliability and validity [<xref ref-type="bibr" rid="ref54">54</xref>]. Each item is rated on a scale from 1 (completely disagree) to 5 (completely agree), with higher scores indicating more acceptability and appropriateness.</p><p>To assess usability of CS PTSD Coach and the mobile app itself (depending on intervention group), we use the System Usability Scale [<xref ref-type="bibr" rid="ref55">55</xref>] that consists of 10 items rating users&#x2019; perceived usability of a system, which has strong reliability and validity [<xref ref-type="bibr" rid="ref55">55</xref>]. Higher scores indicate greater usability. We expect &#x201C;good&#x201D; usability, defined as a score of &#x003E;68 [<xref ref-type="bibr" rid="ref55">55</xref>].</p></sec></sec><sec id="s2-8"><title>Data Collection and Management</title><p>Data are captured and managed using a secure Research Electronic Data Capture database (REDCap; Vanderbilt University) [<xref ref-type="bibr" rid="ref56">56</xref>], created and maintained at the statistical consulting center of the host university, Florida International University. The database includes value, range, and logic checks, and undergoes 2 levels of internal system testing and revision to ensure data integrity. Data collection follows the schedule outlined earlier, which includes baseline sociodemographic information; mental health assessments (PTSD, depression, anxiety, and sleep disturbance); and postintervention evaluations of satisfaction, feasibility, and acceptability. University-based assessors enter data directly into REDCap, linked to unique IDs. Access to participant identifiers is restricted to the study coordinator and data entry team, and REDCap&#x2019;s built-in quality checks help detect inappropriate values.</p><p>All data are securely stored in the Amazon Web Services cloud with encryption both in transit and at rest. The REDCap environment is protected by virtual firewalls and requires 2-factor authentication for access. App usage data collected by the VA will be identified solely by randomly generated invitation codes, ensuring full de-identification. The host university will maintain a secure linkage file connecting app use data with participant identifiers. Upon completion of data collection, deidentified data will be exported for analysis. Long-term data access and archival will follow the host university&#x2019;s Division of Information Technology Security Office policies, ensuring compliance with health information privacy standards.</p></sec><sec id="s2-9"><title>Statistical Analysis Plan</title><p>In aim 1 (feasibility), we will assess the feasibility of PTSD Coach with multiethnic GRs in Florida. App use data obtained from the VA will be summarized descriptively with mean (SD) for continuous variables (eg, time spent in the app) and frequency (N) and percent (%) for categorical variables (eg, modules completed). The use patterns will be examined by the intervention group (CS vs SM) and language (English vs Spanish) used.</p><p>In aim 2 (acceptability), we will evaluate the acceptability of the CS PTSD Coach intervention. Satisfaction is assessed using the Client Satisfaction Questionnaire, with ratings of &#x201C;good&#x201D; or &#x201C;excellent&#x201D; indicating endorsement. Acceptability and appropriateness are measured using the Acceptability of Intervention Measure and the Intervention Appropriateness Measure, with agreement ratings serving as indicators of positive reception. Data will be summarized with mean (SD) for continuous variables and frequency and percent for categorical variables. The data will be summarized for the entire cohort and by both intervention and language groups.</p><p>In aim 3 (efficacy), we will evaluate the efficacy of CS PTSD Coach in reducing symptoms of PTSD, depression, anxiety, and sleep disturbance when compared with SM PTSD Coach and the waitlist control group. Changes in symptoms are measured using the PCL-5 for PTSD, PHQ-9 for depression, GAD-7 for anxiety, and ISI for sleep disturbance. Exploratory analyses will assess the responsiveness of specific PTSD symptom clusters to the 2 interventions [<xref ref-type="bibr" rid="ref38">38</xref>]. Within-group changes will be summarized descriptively (mean change and 95% CIs) to aid interpretation.</p><p>The primary analysis will compare postintervention (8 weeks) outcomes between intervention groups using ANCOVA, adjusting for baseline outcome values and prespecified covariates (eg, language group). The primary estimand is the between-group difference in change from baseline to 8 weeks.</p><p>Separate ANCOVA models will be done to compare between-group changes from baseline to 12-week follow-up (secondary analysis) and from postintervention to 12-week follow-up (exploratory analysis). The sample size and power calculations are applicable to all ANCOVA models.</p><p>All analyses will follow an intent-to-treat framework, with missing outcome data addressed through multiple imputation and sensitivity analysis. Exploratory moderation analyses will be conducted by including prespecified interaction terms in ANCOVA models. Exploratory mediation analyses will be conducted using established regression-based approaches.</p></sec><sec id="s2-10"><title>Ethical Considerations</title><p>Institutional review board (IRB) approval for the study was obtained under protocol IRB-24&#x2010;0383 at Florida International University. The informed consent process is conducted online via the REDCap platform by the recruitment team, ensuring secure data collection and participant confidentiality. Participants are assigned unique study IDs, and their data will be deidentified for analysis. Only authorized personnel will have access to identifying information, which will be stored separately and destroyed after the final follow-up assessment. All staff involved in the study completed training in CITI Human Subjects and Good Clinical Practice, meeting ethical standards and data protection.</p><p>Safety monitoring is overseen by multiple principal investigators, coinvestigators, and the project coordinator. Biweekly meetings address data safety issues, with monthly reviews involving all investigators. Serious adverse events (SAEs) and adverse events are monitored, with SAEs reported to the university IRB and Centers for Disease Control and Prevention or NIOSH as required. Participants experiencing SAEs or adverse events continue in the study if deemed safe by the IRB and clinical team; otherwise, the assigned intervention is discontinued. Additional safeguards include emergency protocols for participants experiencing psychological distress, including suicidal ideation, and procedures to maintain confidentiality during online sessions. Participants may discontinue their assigned intervention at any time upon request.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><p>This manuscript describes the protocol for an RCT evaluating CS and SM versions of PTSD Coach among WTC responders living in Florida. The notice of award was received in September 2024, and IRB approval with amendments was granted in January 2025. Recruitment began in February 2025, with data collection beginning with the first participant in March 2025. As of April 2026, 63 participants have been enrolled, and complete outcome data collection is ongoing. Data analysis will commence following completion of follow-up assessments, with results expected to be disseminated in 2027.</p><p>Aggregated results will be included in peer-reviewed publications and presentations at conferences. We will also post findings to ClinicalTrials.gov. Findings will be conveyed to NIOSH and other relevant agencies, as required. The aims and details of the projects will also be disseminated to the wider public. The study protocol will be publicly available through trial registration and publication; individual participant data will not be shared due to privacy considerations.</p></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><p>This protocol describes an RCT designed to evaluate the feasibility, acceptability, and efficacy of CS and SM versions of PTSD Coach among WTC GRs residing in Florida. Persistent mental health symptoms, combined with documented barriers to specialty care and geographic dispersion, underscore the need for scalable, accessible interventions tailored to this aging and increasingly mobile population.</p><p>The study addresses several critical gaps in the literature. Although PTSD Coach has demonstrated promise among military veteran populations, it has not previously been evaluated with WTC GRs, nor adapted for Spanish-speaking responders. By examining both CS and SM delivery models within a single trial, this study will generate comparative data on the role of human support in enhancing engagement and clinical benefit from digital mental health tools. The inclusion of bilingual delivery further advances equity by addressing linguistic barriers that contribute to unmet mental health needs among Spanish-speaking Hispanic responders.</p><p>Key strengths of the study include its randomized controlled design, use of validated outcome measures aligned with the WTCHP monitoring system, and integration of feasibility and acceptability outcomes alongside symptom change. Embedding the intervention within the context of the WTCHP and the National Provider Network enhances clinical relevance and positions the findings to inform real-world implementation should the intervention prove effective.</p><p>Several anticipated limitations warrant consideration. Recruitment may be challenged by responder aging, comorbid medical conditions, and variability in comfort with mobile technology. Attrition is a known risk in app-based interventions and may differentially affect study arms. In addition, findings may not generalize to responders living outside Florida or to those without access to smartphones or stable internet connectivity. These factors will be carefully monitored and reported to inform interpretation of study outcomes.</p><p>If successful, this trial has the potential to inform scalable mental health service delivery models for WTC responders and other disaster-exposed populations facing similar access barriers. Results will guide future effectiveness and implementation studies and may support broader integration of clinician-supported digital interventions within occupational health and disaster response systems.</p></sec></body><back><ack><p>Generative artificial intelligence (GenAI) was used in the writing process. According to the Generative AI Delegation Taxonomy (2025), the following tasks were delegated to GenAI tools under full human supervision: proofreading and editing. The GenAI tool used was Microsoft Copilot, Enterprise Edition. Responsibility for the final manuscript lies entirely with the authors. GenAI tools are not listed as authors and do not bear responsibility for the final outcomes.</p></ack><notes><sec><title>Funding</title><p>The project is supported by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) as part of a financial assistance award totaling US $699,879 with full funding by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS or the US Government.</p></sec></notes><fn-group><fn fn-type="conflict"><p>None declared.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">ANCOVA</term><def><p>analysis of covariance</p></def></def-item><def-item><term id="abb2">CS</term><def><p>clinician-supported</p></def></def-item><def-item><term id="abb3">GAD-7</term><def><p>Generalized Anxiety Disorder-7</p></def></def-item><def-item><term id="abb4">GR</term><def><p>general responder</p></def></def-item><def-item><term id="abb5">GRDC</term><def><p>General Responder Data Center</p></def></def-item><def-item><term id="abb6">IRB</term><def><p>institutional review board</p></def></def-item><def-item><term id="abb7">ISI</term><def><p>Insomnia Severity Index</p></def></def-item><def-item><term id="abb8">NIOSH</term><def><p>National Institute for Occupational Safety and Health</p></def></def-item><def-item><term id="abb9">PCL-5</term><def><p>PTSD Checklist for DSM-5</p></def></def-item><def-item><term id="abb10">PHQ-9</term><def><p>Patient Health Questionnaire</p></def></def-item><def-item><term id="abb11">PTSD</term><def><p>posttraumatic stress disorder</p></def></def-item><def-item><term id="abb12">RCT</term><def><p>randomized controlled trial</p></def></def-item><def-item><term id="abb13">SAE</term><def><p>serious adverse event</p></def></def-item><def-item><term id="abb14">SM</term><def><p>self-managed</p></def></def-item><def-item><term id="abb15">VA</term><def><p>Veterans Affairs</p></def></def-item><def-item><term id="abb16">WTC</term><def><p>World Trade Center</p></def></def-item><def-item><term id="abb17">WTCHP</term><def><p>World Trade Center Health Program</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calvert</surname><given-names>GM</given-names> </name><name name-style="western"><surname>Reissman</surname><given-names>D</given-names> </name><name name-style="western"><surname>Howard</surname><given-names>J</given-names> </name></person-group><article-title>World Trade Center Health Program: 20 years after 9/11</article-title><source>Occup Environ Med</source><year>2021</year><month>10</month><volume>78</volume><issue>10</issue><fpage>697</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1136/oemed-2021-107770</pub-id><pub-id pub-id-type="medline">34507964</pub-id></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="web"><article-title>World Trade Center Health Program at a Glance as of March 31st, 2023</article-title><source>US Centers for Disease Control and Prevention</source><access-date>2026-03-05</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/wtc/pdfs/statistics/paag20230331-P.pdf">https://www.cdc.gov/wtc/pdfs/statistics/paag20230331-P.pdf</ext-link></comment></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lowell</surname><given-names>A</given-names> </name><name name-style="western"><surname>Suarez-Jimenez</surname><given-names>B</given-names> </name><name name-style="western"><surname>Helpman</surname><given-names>L</given-names> </name><etal/></person-group><article-title>9/11-related PTSD among highly exposed populations: a systematic review 15 years after the attack</article-title><source>Psychol Med</source><year>2018</year><month>03</month><volume>48</volume><issue>4</issue><fpage>537</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1017/S0033291717002033</pub-id><pub-id pub-id-type="medline">28805168</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daniels</surname><given-names>RD</given-names> </name><name name-style="western"><surname>Kubale</surname><given-names>TL</given-names> </name><name name-style="western"><surname>Reissman</surname><given-names>DB</given-names> </name><name name-style="western"><surname>Howard</surname><given-names>J</given-names> </name></person-group><article-title>The World Trade Center Health Program: twenty years of health effects research</article-title><source>Am J Ind Med</source><year>2021</year><month>10</month><volume>64</volume><issue>10</issue><fpage>797</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1002/ajim.23273</pub-id><pub-id pub-id-type="medline">34558722</pub-id></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Slavish</surname><given-names>DC</given-names> </name><name name-style="western"><surname>Ruggero</surname><given-names>CJ</given-names> </name><name name-style="western"><surname>Briggs</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Longitudinal associations between PTSD and sleep disturbances among World Trade Center responders</article-title><source>Sleep Med</source><year>2023</year><month>01</month><volume>101</volume><fpage>269</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1016/j.sleep.2022.11.021</pub-id><pub-id pub-id-type="medline">36462305</pub-id></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trivedi</surname><given-names>NU</given-names> </name><name name-style="western"><surname>Gargano</surname><given-names>LM</given-names> </name><name name-style="western"><surname>Brackbill</surname><given-names>RM</given-names> </name><name name-style="western"><surname>Jacobson</surname><given-names>MH</given-names> </name></person-group><article-title>Posttraumatic stress disorder and functional impairment among World Trade Center Health Registry enrollees 14-15 years after the September 11, 2001, terrorist attacks</article-title><source>J Trauma Stress</source><year>2023</year><month>02</month><volume>36</volume><issue>1</issue><fpage>44</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1002/jts.22887</pub-id><pub-id pub-id-type="medline">36239980</pub-id></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blevins</surname><given-names>CA</given-names> </name><name name-style="western"><surname>Weathers</surname><given-names>FW</given-names> </name><name name-style="western"><surname>Davis</surname><given-names>MT</given-names> </name><name name-style="western"><surname>Witte</surname><given-names>TK</given-names> </name><name name-style="western"><surname>Domino</surname><given-names>JL</given-names> </name></person-group><article-title>The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): development and initial psychometric evaluation</article-title><source>J Trauma Stress</source><year>2015</year><month>12</month><volume>28</volume><issue>6</issue><fpage>489</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1002/jts.22059</pub-id><pub-id pub-id-type="medline">26606250</pub-id></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C</given-names> </name><name name-style="western"><surname>Salim</surname><given-names>R</given-names> </name><name name-style="western"><surname>Rodriguez</surname><given-names>J</given-names> </name><etal/></person-group><article-title>The burden of subthreshold posttraumatic stress disorder in World Trade Center responders in the second decade after 9/11</article-title><source>J Clin Psychiatry</source><year>2020</year><month>01</month><day>21</day><volume>81</volume><issue>1</issue><fpage>19m12881</fpage><pub-id pub-id-type="doi">10.4088/JCP.19m12881</pub-id><pub-id pub-id-type="medline">31967749</pub-id></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lowe</surname><given-names>SM</given-names> </name><name name-style="western"><surname>Haugen</surname><given-names>PT</given-names> </name><name name-style="western"><surname>Rosen</surname><given-names>R</given-names> </name><name name-style="western"><surname>Werth</surname><given-names>AS</given-names> </name></person-group><article-title>World Trade Center psychological exposures and trauma related disorders: PTSD and adjustment disorders</article-title><source>Arch Environ Occup Health</source><year>2023</year><volume>78</volume><issue>4</issue><fpage>216</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1080/19338244.2023.2188153</pub-id><pub-id pub-id-type="medline">36927280</pub-id></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diab</surname><given-names>O</given-names> </name><name name-style="western"><surname>DePierro</surname><given-names>J</given-names> </name><name name-style="western"><surname>Cancelmo</surname><given-names>L</given-names> </name><etal/></person-group><article-title>Mental healthcare needs in World Trade Center responders: results from a large, population-based health monitoring cohort</article-title><source>Adm Policy Ment Health</source><year>2020</year><month>05</month><volume>47</volume><issue>3</issue><fpage>427</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1007/s10488-019-00998-z</pub-id><pub-id pub-id-type="medline">31776767</pub-id></nlm-citation></ref><ref id="ref11"><label>11</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Green</surname><given-names>DC</given-names> </name><name name-style="western"><surname>Buehler</surname><given-names>JW</given-names> </name><name name-style="western"><surname>Silk</surname><given-names>BJ</given-names> </name><etal/></person-group><article-title>Trends in healthcare use in the New York City region following the terrorist attacks of 2001</article-title><source>Biosecur Bioterror</source><year>2006</year><volume>4</volume><issue>3</issue><fpage>263</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1089/bsp.2006.4.263</pub-id><pub-id pub-id-type="medline">16999587</pub-id></nlm-citation></ref><ref id="ref12"><label>12</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghuman</surname><given-names>SJ</given-names> </name><name name-style="western"><surname>Brackbill</surname><given-names>RM</given-names> </name><name name-style="western"><surname>Stellman</surname><given-names>SD</given-names> </name><name name-style="western"><surname>Farfel</surname><given-names>MR</given-names> </name><name name-style="western"><surname>Cone</surname><given-names>JE</given-names> </name></person-group><article-title>Unmet mental health care need 10-11 years after the 9/11 terrorist attacks: 2011-2012 results from the World Trade Center Health Registry</article-title><source>BMC Public Health</source><year>2014</year><month>05</month><day>22</day><volume>14</volume><fpage>491</fpage><pub-id pub-id-type="doi">10.1186/1471-2458-14-491</pub-id><pub-id pub-id-type="medline">24885506</pub-id></nlm-citation></ref><ref id="ref13"><label>13</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brackbill</surname><given-names>RM</given-names> </name><name name-style="western"><surname>Stellman</surname><given-names>SD</given-names> </name><name name-style="western"><surname>Perlman</surname><given-names>SE</given-names> </name><name name-style="western"><surname>Walker</surname><given-names>DJ</given-names> </name><name name-style="western"><surname>Farfel</surname><given-names>MR</given-names> </name></person-group><article-title>Mental health of those directly exposed to the World Trade Center disaster: unmet mental health care need, mental health treatment service use, and quality of life</article-title><source>Soc Sci Med</source><year>2013</year><month>03</month><volume>81</volume><fpage>110</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.socscimed.2012.12.016</pub-id><pub-id pub-id-type="medline">23337833</pub-id></nlm-citation></ref><ref id="ref14"><label>14</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwartz</surname><given-names>RM</given-names> </name><name name-style="western"><surname>Shaam</surname><given-names>P</given-names> </name><name name-style="western"><surname>Williams</surname><given-names>MS</given-names> </name><etal/></person-group><article-title>Understanding mental health needs and gathering feedback on transcutaneous auricular vagus nerve stimulation as a potential PTSD treatment among 9/11 responders living with PTSD symptoms 20 years later: a qualitative approach</article-title><source>Int J Environ Res Public Health</source><year>2022</year><month>04</month><day>16</day><volume>19</volume><issue>8</issue><fpage>4847</fpage><pub-id pub-id-type="doi">10.3390/ijerph19084847</pub-id><pub-id pub-id-type="medline">35457714</pub-id></nlm-citation></ref><ref id="ref15"><label>15</label><nlm-citation citation-type="web"><article-title>WTC STAC suggestions for research recommendations</article-title><source>Centers for Disease Control and Prevention</source><year>2012</year><access-date>2026-06-04</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/niosh/docket/archive/pdfs/NIOSH-248/0248-Draft_research_recs_doc.pdf">https://www.cdc.gov/niosh/docket/archive/pdfs/NIOSH-248/0248-Draft_research_recs_doc.pdf</ext-link></comment></nlm-citation></ref><ref id="ref16"><label>16</label><nlm-citation citation-type="web"><article-title>Recommendations to the WTCHP research program</article-title><source>Centers for Disease Control and Prevention</source><year>2014</year><access-date>2026-06-04</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/wtc/pdfs/stac/RecommendationsforResearchfromSTAC-508.pdf">https://www.cdc.gov/wtc/pdfs/stac/RecommendationsforResearchfromSTAC-508.pdf</ext-link></comment></nlm-citation></ref><ref id="ref17"><label>17</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madrigano</surname><given-names>J</given-names> </name><name name-style="western"><surname>Concannon</surname><given-names>TW</given-names> </name><name name-style="western"><surname>Mann</surname><given-names>S</given-names> </name><name name-style="western"><surname>Siddiqi</surname><given-names>SM</given-names> </name><name name-style="western"><surname>Chari</surname><given-names>R</given-names> </name><name name-style="western"><surname>Faherty</surname><given-names>LJ</given-names> </name></person-group><article-title>Impact of World Trade Center-related health research: an application of the NIEHS translational framework</article-title><source>Int J Environ Res Public Health</source><year>2021</year><month>03</month><day>6</day><volume>18</volume><issue>5</issue><fpage>2659</fpage><pub-id pub-id-type="doi">10.3390/ijerph18052659</pub-id><pub-id pub-id-type="medline">33800881</pub-id></nlm-citation></ref><ref id="ref18"><label>18</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><collab>CATS Consortium</collab></person-group><article-title>Implementation of CBT for youth affected by the World Trade Center disaster: matching need to treatment intensity and reducing trauma symptoms</article-title><source>J Trauma Stress</source><year>2010</year><month>12</month><volume>23</volume><issue>6</issue><fpage>699</fpage><lpage>707</lpage><pub-id pub-id-type="doi">10.1002/jts.20594</pub-id><pub-id pub-id-type="medline">21171130</pub-id></nlm-citation></ref><ref id="ref19"><label>19</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Difede</surname><given-names>J</given-names> </name><name name-style="western"><surname>Malta</surname><given-names>LS</given-names> </name><name name-style="western"><surname>Best</surname><given-names>S</given-names> </name><etal/></person-group><article-title>A randomized controlled clinical treatment trial for World Trade Center attack-related PTSD in disaster workers</article-title><source>J Nerv Ment Dis</source><year>2007</year><month>10</month><volume>195</volume><issue>10</issue><fpage>861</fpage><lpage>865</lpage><pub-id pub-id-type="doi">10.1097/NMD.0b013e3181568612</pub-id><pub-id pub-id-type="medline">18043528</pub-id></nlm-citation></ref><ref id="ref20"><label>20</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haugen</surname><given-names>PT</given-names> </name><name name-style="western"><surname>Goldman</surname><given-names>RE</given-names> </name><name name-style="western"><surname>Owen</surname><given-names>J</given-names> </name></person-group><article-title>Sudden gains and deteriorations in the treatment of posttraumatic stress disorder in World Trade Center responders</article-title><source>J Nerv Ment Dis</source><year>2015</year><month>03</month><volume>203</volume><issue>3</issue><fpage>205</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1097/NMD.0000000000000263</pub-id><pub-id pub-id-type="medline">25674885</pub-id></nlm-citation></ref><ref id="ref21"><label>21</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haugen</surname><given-names>PT</given-names> </name><name name-style="western"><surname>Splaun</surname><given-names>AK</given-names> </name><name name-style="western"><surname>Evces</surname><given-names>MR</given-names> </name><name name-style="western"><surname>Weiss</surname><given-names>DS</given-names> </name></person-group><article-title>Integrative approach for the treatment of posttraumatic stress disorder in 9/11 first responders: three core techniques</article-title><source>Psychotherapy (Chic)</source><year>2013</year><month>09</month><volume>50</volume><issue>3</issue><fpage>336</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1037/a0032526</pub-id><pub-id pub-id-type="medline">24000847</pub-id></nlm-citation></ref><ref id="ref22"><label>22</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levitt</surname><given-names>JT</given-names> </name><name name-style="western"><surname>Malta</surname><given-names>LS</given-names> </name><name name-style="western"><surname>Martin</surname><given-names>A</given-names> </name><name name-style="western"><surname>Davis</surname><given-names>L</given-names> </name><name name-style="western"><surname>Cloitre</surname><given-names>M</given-names> </name></person-group><article-title>The flexible application of a manualized treatment for PTSD symptoms and functional impairment related to the 9/11 World Trade Center attack</article-title><source>Behav Res Ther</source><year>2007</year><month>07</month><volume>45</volume><issue>7</issue><fpage>1419</fpage><lpage>1433</lpage><pub-id pub-id-type="doi">10.1016/j.brat.2007.01.004</pub-id><pub-id pub-id-type="medline">17350590</pub-id></nlm-citation></ref><ref id="ref23"><label>23</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Difede</surname><given-names>J</given-names> </name><name name-style="western"><surname>Cukor</surname><given-names>J</given-names> </name><name name-style="western"><surname>Patt</surname><given-names>I</given-names> </name><name name-style="western"><surname>Giosan</surname><given-names>C</given-names> </name><name name-style="western"><surname>Hoffman</surname><given-names>H</given-names> </name></person-group><article-title>The application of virtual reality to the treatment of PTSD following the WTC attack</article-title><source>Ann N Y Acad Sci</source><year>2006</year><month>07</month><volume>1071</volume><fpage>500</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1196/annals.1364.052</pub-id><pub-id pub-id-type="medline">16891607</pub-id></nlm-citation></ref><ref id="ref24"><label>24</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneier</surname><given-names>FR</given-names> </name><name name-style="western"><surname>Neria</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Pavlicova</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial</article-title><source>Am J Psychiatry</source><year>2012</year><month>01</month><volume>169</volume><issue>1</issue><fpage>80</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2011.11020321</pub-id><pub-id pub-id-type="medline">21908494</pub-id></nlm-citation></ref><ref id="ref25"><label>25</label><nlm-citation citation-type="web"><article-title>WTCHP nationwide provider network</article-title><source>SAM.gov</source><access-date>2026-06-04</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://sam.gov/opp/10d83b1d5da84a418b37c8f7ffe9e556/view">https://sam.gov/opp/10d83b1d5da84a418b37c8f7ffe9e556/view</ext-link></comment></nlm-citation></ref><ref id="ref26"><label>26</label><nlm-citation citation-type="web"><article-title>World Trade Center Health Program external quarterly program summary: program data through September 30, 2025</article-title><source>US Centers for Disease Control and Prevention</source><access-date>2026-03-05</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/wtc/pdfs/statistics/20250930_External_QuarterlyProgramSummary.pdf">https://www.cdc.gov/wtc/pdfs/statistics/20250930_External_QuarterlyProgramSummary.pdf</ext-link></comment></nlm-citation></ref><ref id="ref27"><label>27</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Possemato</surname><given-names>K</given-names> </name><name name-style="western"><surname>Kuhn</surname><given-names>E</given-names> </name><name name-style="western"><surname>Johnson</surname><given-names>E</given-names> </name><etal/></person-group><article-title>Using PTSD Coach in primary care with and without clinician support: a pilot randomized controlled trial</article-title><source>Gen Hosp Psychiatry</source><year>2016</year><volume>38</volume><fpage>94</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.genhosppsych.2015.09.005</pub-id><pub-id pub-id-type="medline">26589765</pub-id></nlm-citation></ref><ref id="ref28"><label>28</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Possemato</surname><given-names>K</given-names> </name><name name-style="western"><surname>Johnson</surname><given-names>E</given-names> </name><name name-style="western"><surname>Barrie</surname><given-names>K</given-names> </name><etal/></person-group><article-title>A randomized clinical trial of clinician-supported PTSD Coach in VA primary care patients</article-title><source>J Gen Intern Med</source><year>2023</year><month>07</month><volume>38</volume><issue>Suppl 3</issue><fpage>905</fpage><lpage>912</lpage><pub-id pub-id-type="doi">10.1007/s11606-023-08130-6</pub-id><pub-id pub-id-type="medline">36932268</pub-id></nlm-citation></ref><ref id="ref29"><label>29</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chorpita</surname><given-names>BF</given-names> </name><name name-style="western"><surname>Barlow</surname><given-names>DH</given-names> </name><name name-style="western"><surname>Albano</surname><given-names>AM</given-names> </name><name name-style="western"><surname>Daleiden</surname><given-names>EL</given-names> </name></person-group><article-title>Methodological strategies in child clinical trials: advancing the efficacy and effectiveness of psychosocial treatments</article-title><source>J Abnorm Child Psychol</source><year>1998</year><month>02</month><volume>26</volume><issue>1</issue><fpage>7</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1023/a:1022626505280</pub-id><pub-id pub-id-type="medline">9566542</pub-id></nlm-citation></ref><ref id="ref30"><label>30</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schueller</surname><given-names>SM</given-names> </name><name name-style="western"><surname>Tomasino</surname><given-names>KN</given-names> </name><name name-style="western"><surname>Mohr</surname><given-names>DC</given-names> </name></person-group><article-title>Integrating human support into behavioral intervention technologies: the efficiency model of support</article-title><source>Clin Psychol Sci Pract</source><year>2017</year><volume>24</volume><issue>1</issue><fpage>27</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1037/h0101740</pub-id></nlm-citation></ref><ref id="ref31"><label>31</label><nlm-citation citation-type="web"><article-title>AUDIT: the Alcohol Use Disorders Identification Test: guidelines for use in primary health care</article-title><source>World Health Organization</source><year>2001</year><access-date>2026-06-04</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications/i/item/WHO-MSD-MSB-01.6a">https://www.who.int/publications/i/item/WHO-MSD-MSB-01.6a</ext-link></comment></nlm-citation></ref><ref id="ref32"><label>32</label><nlm-citation citation-type="web"><article-title>LEVEL 2&#x2014;substance use&#x2014;Adult (adapted from the NIDA-modified ASSIST)</article-title><source>National Institute on Drug Abuse</source><access-date>2026-06-04</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.psychiatry.org/getmedia/cf5e60dd-6452-4b1b-a42f-40a7d46b410b/APA-DSM5TR-Level2SubstanceUseAdult.pdf">https://www.psychiatry.org/getmedia/cf5e60dd-6452-4b1b-a42f-40a7d46b410b/APA-DSM5TR-Level2SubstanceUseAdult.pdf</ext-link></comment></nlm-citation></ref><ref id="ref33"><label>33</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katzman</surname><given-names>R</given-names> </name><name name-style="western"><surname>Brown</surname><given-names>T</given-names> </name><name name-style="western"><surname>Fuld</surname><given-names>P</given-names> </name><name name-style="western"><surname>Peck</surname><given-names>A</given-names> </name><name name-style="western"><surname>Schechter</surname><given-names>R</given-names> </name><name name-style="western"><surname>Schimmel</surname><given-names>H</given-names> </name></person-group><article-title>Validation of a short Orientation-Memory-Concentration Test of cognitive impairment</article-title><source>Am J Psychiatry</source><year>1983</year><month>06</month><volume>140</volume><issue>6</issue><fpage>734</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1176/ajp.140.6.734</pub-id><pub-id pub-id-type="medline">6846631</pub-id></nlm-citation></ref><ref id="ref34"><label>34</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuhn</surname><given-names>E</given-names> </name><name name-style="western"><surname>Greene</surname><given-names>C</given-names> </name><name name-style="western"><surname>Hoffman</surname><given-names>J</given-names> </name><etal/></person-group><article-title>Preliminary evaluation of PTSD Coach, a smartphone app for post-traumatic stress symptoms</article-title><source>Mil Med</source><year>2014</year><month>01</month><volume>179</volume><issue>1</issue><fpage>12</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.7205/MILMED-D-13-00271</pub-id><pub-id pub-id-type="medline">24402979</pub-id></nlm-citation></ref><ref id="ref35"><label>35</label><nlm-citation citation-type="web"><article-title>PTSD coach</article-title><source>United States Department of Veterans Affairs</source><access-date>2026-05-25</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://mobile.va.gov/app/ptsd-coach">https://mobile.va.gov/app/ptsd-coach</ext-link></comment></nlm-citation></ref><ref id="ref36"><label>36</label><nlm-citation citation-type="web"><article-title>Mobile operating system market share United States of America</article-title><source>StatCounter</source><access-date>2026-06-04</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://gs.statcounter.com/os-market-share/mobile/united-states-of-america">https://gs.statcounter.com/os-market-share/mobile/united-states-of-america</ext-link></comment></nlm-citation></ref><ref id="ref37"><label>37</label><nlm-citation citation-type="book"><source>The Diagnostic and Statistical Manual of Mental Disorders</source><year>2013</year><edition>5</edition><publisher-name>American Psychiatric Association</publisher-name></nlm-citation></ref><ref id="ref38"><label>38</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Br&#x00F6;cker</surname><given-names>E</given-names> </name><name name-style="western"><surname>Suliman</surname><given-names>S</given-names> </name><name name-style="western"><surname>Olff</surname><given-names>M</given-names> </name><name name-style="western"><surname>Seedat</surname><given-names>S</given-names> </name></person-group><article-title>Feasibility, acceptability, and effectiveness of web-based and mobile PTSD Coach: a systematic review and meta-analysis</article-title><source>Eur J Psychotraumatol</source><year>2023</year><volume>14</volume><issue>2</issue><fpage>2209469</fpage><pub-id pub-id-type="doi">10.1080/20008066.2023.2209469</pub-id><pub-id pub-id-type="medline">37226885</pub-id></nlm-citation></ref><ref id="ref39"><label>39</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuhn</surname><given-names>E</given-names> </name><name name-style="western"><surname>Kanuri</surname><given-names>N</given-names> </name><name name-style="western"><surname>Hoffman</surname><given-names>JE</given-names> </name><name name-style="western"><surname>Garvert</surname><given-names>DW</given-names> </name><name name-style="western"><surname>Ruzek</surname><given-names>JI</given-names> </name><name name-style="western"><surname>Taylor</surname><given-names>CB</given-names> </name></person-group><article-title>A randomized controlled trial of a smartphone app for posttraumatic stress disorder symptoms</article-title><source>J Consult Clin Psychol</source><year>2017</year><month>03</month><volume>85</volume><issue>3</issue><fpage>267</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1037/ccp0000163</pub-id><pub-id pub-id-type="medline">28221061</pub-id></nlm-citation></ref><ref id="ref40"><label>40</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forkus</surname><given-names>SR</given-names> </name><name name-style="western"><surname>Raudales</surname><given-names>AM</given-names> </name><name name-style="western"><surname>Rafiuddin</surname><given-names>HS</given-names> </name><name name-style="western"><surname>Weiss</surname><given-names>NH</given-names> </name><name name-style="western"><surname>Messman</surname><given-names>BA</given-names> </name><name name-style="western"><surname>Contractor</surname><given-names>AA</given-names> </name></person-group><article-title>The posttraumatic stress disorder (PTSD) checklist for DSM-5: a systematic review of existing psychometric evidence</article-title><source>Clin Psychol (New York)</source><year>2023</year><month>03</month><volume>30</volume><issue>1</issue><fpage>110</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1037/cps0000111</pub-id><pub-id pub-id-type="medline">37378352</pub-id></nlm-citation></ref><ref id="ref41"><label>41</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blanchard</surname><given-names>BE</given-names> </name><name name-style="western"><surname>Johnson</surname><given-names>M</given-names> </name><name name-style="western"><surname>Campbell</surname><given-names>SB</given-names> </name><etal/></person-group><article-title>Minimal important difference metrics and test-retest reliability of the PTSD checklist for DSM-5 with a primary care sample</article-title><source>J Trauma Stress</source><year>2023</year><month>12</month><volume>36</volume><issue>6</issue><fpage>1102</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1002/jts.22975</pub-id><pub-id pub-id-type="medline">37845820</pub-id></nlm-citation></ref><ref id="ref42"><label>42</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Titov</surname><given-names>N</given-names> </name><name name-style="western"><surname>Dear</surname><given-names>BF</given-names> </name><name name-style="western"><surname>McMillan</surname><given-names>D</given-names> </name><name name-style="western"><surname>Anderson</surname><given-names>T</given-names> </name><name name-style="western"><surname>Zou</surname><given-names>J</given-names> </name><name name-style="western"><surname>Sunderland</surname><given-names>M</given-names> </name></person-group><article-title>Psychometric comparison of the PHQ-9 and BDI-II for measuring response during treatment of depression</article-title><source>Cogn Behav Ther</source><year>2011</year><volume>40</volume><issue>2</issue><fpage>126</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1080/16506073.2010.550059</pub-id><pub-id pub-id-type="medline">25155813</pub-id></nlm-citation></ref><ref id="ref43"><label>43</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kroenke</surname><given-names>K</given-names> </name><name name-style="western"><surname>Spitzer</surname><given-names>RL</given-names> </name><name name-style="western"><surname>Williams</surname><given-names>JB</given-names> </name></person-group><article-title>The PHQ-9: validity of a brief depression severity measure</article-title><source>J Gen Intern Med</source><year>2001</year><month>09</month><volume>16</volume><issue>9</issue><fpage>606</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1046/j.1525-1497.2001.016009606.x</pub-id><pub-id pub-id-type="medline">11556941</pub-id></nlm-citation></ref><ref id="ref44"><label>44</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beidel</surname><given-names>DC</given-names> </name><name name-style="western"><surname>Rozek</surname><given-names>DC</given-names> </name><name name-style="western"><surname>Bowers</surname><given-names>CA</given-names> </name><name name-style="western"><surname>Newins</surname><given-names>AR</given-names> </name><name name-style="western"><surname>Steigerwald</surname><given-names>VL</given-names> </name></person-group><article-title>After the fall: responding to the Champlain Towers building collapse</article-title><source>Front Public Health</source><year>2022</year><volume>10</volume><fpage>1104534</fpage><pub-id pub-id-type="doi">10.3389/fpubh.2022.1104534</pub-id><pub-id pub-id-type="medline">36699904</pub-id></nlm-citation></ref><ref id="ref45"><label>45</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manea</surname><given-names>L</given-names> </name><name name-style="western"><surname>Gilbody</surname><given-names>S</given-names> </name><name name-style="western"><surname>McMillan</surname><given-names>D</given-names> </name></person-group><article-title>Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis</article-title><source>CMAJ</source><year>2012</year><month>02</month><day>21</day><volume>184</volume><issue>3</issue><fpage>E191</fpage><lpage>E196</lpage><pub-id pub-id-type="doi">10.1503/cmaj.110829</pub-id><pub-id pub-id-type="medline">22184363</pub-id></nlm-citation></ref><ref id="ref46"><label>46</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spitzer</surname><given-names>RL</given-names> </name><name name-style="western"><surname>Kroenke</surname><given-names>K</given-names> </name><name name-style="western"><surname>Williams</surname><given-names>JB</given-names> </name><name name-style="western"><surname>L&#x00F6;we</surname><given-names>B</given-names> </name></person-group><article-title>A brief measure for assessing generalized anxiety disorder: the GAD-7</article-title><source>Arch Intern Med</source><year>2006</year><month>05</month><day>22</day><volume>166</volume><issue>10</issue><fpage>1092</fpage><lpage>1097</lpage><pub-id pub-id-type="doi">10.1001/archinte.166.10.1092</pub-id><pub-id pub-id-type="medline">16717171</pub-id></nlm-citation></ref><ref id="ref47"><label>47</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>L&#x00F6;we</surname><given-names>B</given-names> </name><name name-style="western"><surname>Decker</surname><given-names>O</given-names> </name><name name-style="western"><surname>M&#x00FC;ller</surname><given-names>S</given-names> </name><etal/></person-group><article-title>Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population</article-title><source>Med Care</source><year>2008</year><month>03</month><volume>46</volume><issue>3</issue><fpage>266</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1097/MLR.0b013e318160d093</pub-id><pub-id pub-id-type="medline">18388841</pub-id></nlm-citation></ref><ref id="ref48"><label>48</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plummer</surname><given-names>F</given-names> </name><name name-style="western"><surname>Manea</surname><given-names>L</given-names> </name><name name-style="western"><surname>Trepel</surname><given-names>D</given-names> </name><name name-style="western"><surname>McMillan</surname><given-names>D</given-names> </name></person-group><article-title>Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis</article-title><source>Gen Hosp Psychiatry</source><year>2016</year><volume>39</volume><fpage>24</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.genhosppsych.2015.11.005</pub-id><pub-id pub-id-type="medline">26719105</pub-id></nlm-citation></ref><ref id="ref49"><label>49</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kroenke</surname><given-names>K</given-names> </name><name name-style="western"><surname>Spitzer</surname><given-names>RL</given-names> </name><name name-style="western"><surname>Williams</surname><given-names>JB</given-names> </name><name name-style="western"><surname>Monahan</surname><given-names>PO</given-names> </name><name name-style="western"><surname>L&#x00F6;we</surname><given-names>B</given-names> </name></person-group><article-title>Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection</article-title><source>Ann Intern Med</source><year>2007</year><month>03</month><day>6</day><volume>146</volume><issue>5</issue><fpage>317</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-146-5-200703060-00004</pub-id><pub-id pub-id-type="medline">17339617</pub-id></nlm-citation></ref><ref id="ref50"><label>50</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bastien</surname><given-names>CH</given-names> </name><name name-style="western"><surname>Valli&#x00E8;res</surname><given-names>A</given-names> </name><name name-style="western"><surname>Morin</surname><given-names>CM</given-names> </name></person-group><article-title>Validation of the Insomnia Severity Index as an outcome measure for insomnia research</article-title><source>Sleep Med</source><year>2001</year><month>07</month><volume>2</volume><issue>4</issue><fpage>297</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1016/s1389-9457(00)00065-4</pub-id><pub-id pub-id-type="medline">11438246</pub-id></nlm-citation></ref><ref id="ref51"><label>51</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morin</surname><given-names>CM</given-names> </name><name name-style="western"><surname>Belleville</surname><given-names>G</given-names> </name><name name-style="western"><surname>B&#x00E9;langer</surname><given-names>L</given-names> </name><name name-style="western"><surname>Ivers</surname><given-names>H</given-names> </name></person-group><article-title>The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response</article-title><source>Sleep</source><year>2011</year><month>05</month><day>1</day><volume>34</volume><issue>5</issue><fpage>601</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1093/sleep/34.5.601</pub-id><pub-id pub-id-type="medline">21532953</pub-id></nlm-citation></ref><ref id="ref52"><label>52</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Attkisson</surname><given-names>CC</given-names> </name><name name-style="western"><surname>Zwick</surname><given-names>R</given-names> </name></person-group><article-title>The Client Satisfaction Questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome</article-title><source>Eval Program Plann</source><year>1982</year><volume>5</volume><issue>3</issue><fpage>233</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/0149-7189(82)90074-x</pub-id><pub-id pub-id-type="medline">10259963</pub-id></nlm-citation></ref><ref id="ref53"><label>53</label><nlm-citation citation-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Attkisson</surname><given-names>CC</given-names> </name><name name-style="western"><surname>Greenfield</surname><given-names>TK</given-names> </name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Maruish</surname><given-names>ME</given-names> </name></person-group><article-title>The UCSF client satisfaction scales: I. The Client Satisfaction Questionnaire-8</article-title><source>The Use of Psychological Testing for Treatment Planning and Outcome Assessment</source><year>2004</year><edition>3</edition><publisher-name>Lawrence Erlbaum Associates</publisher-name><fpage>799</fpage><lpage>811</lpage></nlm-citation></ref><ref id="ref54"><label>54</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiner</surname><given-names>BJ</given-names> </name><name name-style="western"><surname>Lewis</surname><given-names>CC</given-names> </name><name name-style="western"><surname>Stanick</surname><given-names>C</given-names> </name><etal/></person-group><article-title>Psychometric assessment of three newly developed implementation outcome measures</article-title><source>Implement Sci</source><year>2017</year><month>08</month><day>29</day><volume>12</volume><issue>1</issue><fpage>108</fpage><pub-id pub-id-type="doi">10.1186/s13012-017-0635-3</pub-id><pub-id pub-id-type="medline">28851459</pub-id></nlm-citation></ref><ref id="ref55"><label>55</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brooke</surname><given-names>J</given-names> </name></person-group><article-title>SUS: a retrospective</article-title><source>J Usability Stud</source><year>2013</year><volume>8</volume><issue>2</issue><fpage>29</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.5555/2817912.2817913</pub-id></nlm-citation></ref><ref id="ref56"><label>56</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>PA</given-names> </name><name name-style="western"><surname>Taylor</surname><given-names>R</given-names> </name><name name-style="western"><surname>Minor</surname><given-names>BL</given-names> </name><etal/></person-group><article-title>The REDCap consortium: building an international community of software platform partners</article-title><source>J Biomed Inform</source><year>2019</year><month>07</month><volume>95</volume><fpage>103208</fpage><pub-id pub-id-type="doi">10.1016/j.jbi.2019.103208</pub-id><pub-id pub-id-type="medline">31078660</pub-id></nlm-citation></ref></ref-list><app-group><supplementary-material id="app1"><label>Checklist 1</label><p>SPIRIT checklist.</p><media xlink:href="resprot_v15i1e95229_app1.docx" xlink:title="DOCX File, 34 KB"/></supplementary-material><supplementary-material id="app2"><label>Peer Review Report 1</label><p>Peer review report from ZOH1 LEE (52) - Disease, Disability and Injury Prevention and Control Special Emphasis Panel, WTC Research Review, Centers for Disease Control and Prevention-National Institute for Occupational Health and Safety.</p><media xlink:href="resprot_v15i1e95229_app2.pdf" xlink:title="PDF File, 118 KB"/></supplementary-material></app-group></back></article>